US · Technology · Scientific & Technical Instruments
EPS came in at 0.89 against a street estimate of 0.83 — a beat of 7.2%.
Analysts rate Novanta Inc a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $194.50.
CONFIDENT Q2 beat expectations: 9% organic growth, 47% gross margin (+100bps YoY), 16% EBITDA growth. Closed transformative Riverpoint Medical acquisition. Raised FY26 guidance to 15%+ reported growth. All segments grew organically. Q2 2026 Not discussed by geography; Medical 51% of sales, Advanced Industrial 49%. Analysts pressed on Gen AI visibility into 2027 (management confident mid-20% growth continuing, air spindles booked 2 years out), advanced surgery booking timing (management noted 4-Q rolling average >1.0, full-year book-to-bill >1.0), and core margin algorithm (management expects 48% in 2027 despite tariff/inflation headwinds, site closures driving improvement). 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.31% |
| Vanguard Portfolio Management, LLC | 6.55% |
| Allspring Global Investments Holdings, LLC | 4.81% |
| T. Rowe Price Associates, Inc. | 4.72% |
| Vanguard Capital Management, LLC | 4.27% |
| State Street Corp | 3.54% |
| Conestoga Capital Advisors, LLC | 3.22% |
| Congress Asset Management Company, LLP | 2.57% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 NOVANTA INC. - 10-Q SUMMARY (July 3, 2026) HEADLINE NUMBERS • Revenue Q2 2026: $265.8 million (up 10.3% vs. Q2 2025: $241.0 million) • Revenue H1 20 | 2026-08-05 |
| Results announced · Q3 2026 NOVANTA INC. – Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 2026 GAAP revenue: $265.8 million, up 10.3% year-over-year ($24.8 million increase) • | 2026-08-05 |
| Acquisition completed · Q3 2026 NOVANTA INC. - 8-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Acquisition closed July 23, 2026: Novanta completed purchase of Runway Buyer LLC | 2026-07-27 |
| Material agreement · Q2 2026 NOVANTA INC. - 8-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Private placement size: $300.0 million in gross proceeds • Share price in placeme | 2026-06-09 |
| Material agreement · Q2 2026 NOVANTA INC. – 8-K SUMMARY HEADLINE NUMBERS • Acquisition price: $1,200,000,000 in cash at closing (subject to working capital and debt adjustments) | 2026-06-09 |
| Quarterly report · Q2 2026 NOVANTA INC. — Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue: $257.7 million (Q1 2026) vs. $233.4 million (Q1 2025) — up 10.4% year-over-year • Ne | 2026-05-11 |
| Proxy statement · Q2 2026 NOVANTA INC. PROXY STATEMENT SUMMARY CEO COMPENSATION • Matthijs Glastra (Chair and CEO) total compensation for fiscal year 2025: $7,356,000 • Compe | 2026-04-24 |
| Annual report FY2025 NOVANTA INC. — 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Revenue (2025): $980.6 million across two segments - Automation Enabling | 2026-02-23 |
Readable in the app.
| Announcement | Date |
|---|---|
| Completed acquisition of Riverpoint Medical from Arlington Capital Partners Novanta Inc. completed its acquisition of Riverpoint Medical, a leading manufacturer of minimally invasive surgical consumables (surgical fibers for sports medicine, trauma, and cardiovascul | 2026-07-27 |
| Equity purchase agreement to acquire business from Runway Midco Novanta Inc. is acquiring Runway Buyer, LLC (owned by Runway Midco, LLC) through its subsidiary Novanta Medical Technologies Corp. This is a strategic acquisition in the medical technology s | 2026-06-09 |
| Revised Q4 and full year 2025 EPS guidance down due to equity issuance Novanta Inc. completed a recent equity issuance (stock offering) and revised its 2025 earnings guidance downward to reflect share dilution. The company lowered its adjusted diluted earnings | 2025-11-13 |
| Board authorizes additional $200 million share repurchase program Novanta Inc.'s Board of Directors authorized an additional $200 million share repurchase program on September 18, 2025. Combined with the $31 million remaining from a previous 2020 authoriza | 2025-09-18 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Novanta Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.